1. Home
  2. RGEN vs DRS Comparison

RGEN vs DRS Comparison

Compare RGEN & DRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGEN
  • DRS
  • Stock Information
  • Founded
  • RGEN 1981
  • DRS 1969
  • Country
  • RGEN United States
  • DRS United States
  • Employees
  • RGEN N/A
  • DRS N/A
  • Industry
  • RGEN Medical/Dental Instruments
  • DRS Military/Government/Technical
  • Sector
  • RGEN Health Care
  • DRS Industrials
  • Exchange
  • RGEN Nasdaq
  • DRS Nasdaq
  • Market Cap
  • RGEN 8.0B
  • DRS 8.3B
  • IPO Year
  • RGEN N/A
  • DRS N/A
  • Fundamental
  • Price
  • RGEN $126.50
  • DRS $41.67
  • Analyst Decision
  • RGEN Buy
  • DRS Buy
  • Analyst Count
  • RGEN 12
  • DRS 6
  • Target Price
  • RGEN $172.67
  • DRS $38.33
  • AVG Volume (30 Days)
  • RGEN 815.5K
  • DRS 1.1M
  • Earning Date
  • RGEN 04-29-2025
  • DRS 05-01-2025
  • Dividend Yield
  • RGEN N/A
  • DRS 0.43%
  • EPS Growth
  • RGEN N/A
  • DRS 25.90
  • EPS
  • RGEN N/A
  • DRS 0.88
  • Revenue
  • RGEN $650,429,000.00
  • DRS $3,345,000,000.00
  • Revenue This Year
  • RGEN $13.93
  • DRS $9.55
  • Revenue Next Year
  • RGEN $14.35
  • DRS $6.15
  • P/E Ratio
  • RGEN N/A
  • DRS $47.35
  • Revenue Growth
  • RGEN 4.88
  • DRS 13.58
  • 52 Week Low
  • RGEN $102.97
  • DRS $21.98
  • 52 Week High
  • RGEN $182.52
  • DRS $42.62
  • Technical
  • Relative Strength Index (RSI)
  • RGEN 44.61
  • DRS 67.49
  • Support Level
  • RGEN $123.10
  • DRS $40.01
  • Resistance Level
  • RGEN $135.47
  • DRS $43.20
  • Average True Range (ATR)
  • RGEN 6.98
  • DRS 1.59
  • MACD
  • RGEN -0.97
  • DRS -0.07
  • Stochastic Oscillator
  • RGEN 25.20
  • DRS 79.35

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

About DRS Leonardo DRS Inc.

Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. The company is in the design, development, and manufacture of Advanced sensing, network computing, force protection, and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue, and the Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designing, developing, and manufacturing sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision-making and execution by the customers.

Share on Social Networks: